Abstract
Twenty-three adult patients with meningeal involvement by a variety of malignancies were treated with the intra-Ommaya combination of methotrexate, hydrocortisone, cytosine arabinoside, and thio TEPA. Whole brain irradiation was also administered to most patients who had not previously received it. Most patients demonstrated improvement of cerebrospinal fluid parameters, but only 50% of the patients experienced neurological improvement. Patients who did not receive cranial irradiation and performance status 4 patients were less likely to respond than were patients who did receive cranial irradiation as part of their treatment and patients who were performance status 0–3. Four patients developed possible and 2 patients developed probable or definite serious neurological complications. Another 4 patients developed less severe, reversible neurological toxicity. It is possible (but still uncertain) that this regimen is more toxic than other less intensive regimens, and further studies should be undertaken cautiously.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aur RJA, Hustu HO, Verzosa MS, Wood A, Simone JV: Comparison of two methods of preventing central nervous system leukemia. Blood 42:349–357, 1973
Inati A, Sallan SE, Cassady JR, Hitchcock-Bryan S, Clavell LA, Belli JA, Sollee N: Efficacy and morbidity of central nervous system “prophylaxis” in childhood acute lymphoblastic leukemia: eight years' experience with cranial irradiation and intrathecal methotrexate. Blood 61:297–303, 1983
Sullivan MP, Moon TE, Trueworthy R, Vietti TJ, Humphrey GB, Kemp D: Combination intrathecal therapy for meningeal leukemia: two versus three drugs. Blood 51:471–479, 1977
Stewart DJ, Smith TL, Keating MJ, Maor M, Leavens M, Hurtubise M, McCredie KB, Bodey GP Sr, Freireich EJ: Remission from central nervous system involvement in adults with acute leukemia: Effect of intensive therapy and prognostic factors. Cancer 56:632–641, 1985
Shapiro WR, Young DF, Mehta BM: Methotrexate: Distribution in cerebral fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293:161–166, 1975
Shapiro W, Posner J, Ushio Y, Chernik N, Young D: Treatment of meningeal neoplasms. Cancer Treat Rep 61:733–743, 1977
Bleyer WA, Poplack D: Intraventricular vs intralumbar methotrexate for central nervous system leukemia: prolonged remission with the Ommaya reservoir. Med Ped Oncol 6:207–213, 1979
Gutin PH, Weiss HD, Wiernik PH, et al.: Intrathecal N,N′, N″-triethylenethiophosphoramide [thioTEPA(NSC 6396)] in the treatment of malignant meningeal disease. Phase I–II study. Cancer 38:1471–1475, 1976
Gutin P, Levi J, Wiernik P, Walker M: Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study. Cancer Treat Rep 61:885–887, 1977
Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol 30:122–127, 1974
Aisner J, Ostrow S, Govindan S, Wiernik P: Leptomeningeal carcinomatosis in small cell carcinoma of the lung. Med Ped Oncol 9:47–59, 1981
Yap HY, Yap BS, Tashima C, DiStefano A, Blumenschein G: Meningeal carcinomatosis in breast cancer. Cancer 42:283–286, 1978
Lokich J, Galbo C: Leptomeningeal lymphoma: perspectives on management. Cancer Treat Rev 8:103–110, 1981
MacKintosh F, Colby T, Podolsky W, Burke J, Hoppe R, Rosenfelt F, Rosenberg S, Kaplan H: Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 cases. Cancer 49:586–595, 1982
Yap HY, Yap BS, Rasmussen S, Leavens M, Hortobagyi G, Blumenschein G: Treatment for meningeal carcinomatosis in breast cancer. Cancer 49:219–222, 1982
Ongerboer de Visser B, Somers R, Nooyen W, van Heerde P, Hart A, McVie J: Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology 33:1565–1572, 1983
Wasserstrom W, Glass JP, Posner J: Diagnosis and treatment of leptomeningeal metastasis from solid tumors: experience with 90 patients. Cancer 49:759–772, 1982
Fulton D, Levin V, Gutin P, Edwards M, Seager M, Stewart J, Wilson C: Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors. Cancer Chemother Pharmacol 8:285–291, 1982
Blasberg RG: Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion Cancer Treat Rep 61:625–632, 1977
Jacobs A, Clifford P, Kay H: The Ommaya reservoir in chemotherapy for malignant disease in the CNS. Clinical Oncol 7:123–129, 1981
Bleyer WA, Pizzo P, Spence A, Platt W, Benjamin D, Kolins J, Poplack D: The Ommaya reservoir. Newly recognized complications and recommendations for insertion and use. Cancer 41:2431–2437, 1978
Bleyer WA, Drake JC, Chabner BA: Methotrexate neurotoxicity. N Engl J Med 57:290, 1974
Saiki JH, Thompson S, Smith F, Atkinson R: Paraplegia following intrathecal chemotherapy. Cancer 29:370–374, 1972
Ushio Y, Posner J, Shapiro W: Chemotherapy of experimental meningeal carcinomatosis. Cancer Res 37:1232–1237, 1977
Stewart DJ, Benvenuto JA; Leavens M, Hall SW, Benjamin RS, Plunkett W, McCredie KD, Burgess MA, Loo TL: Penetration of 3-Deazauridine into human brain, intracerebral tumor and cerebrospinal fluid. Cancer Research 39:4119–4112, 1979
Stewart DJ, Leavens M, Friedman J, Benjamin RS, Moore EC, Bodey GP, Valdivieso M, Burgess MA, Wiseman C, Loo TL: Penetration of N-(Phosphonacetyl)-L-aspartate into Human Central Nervous System and Intracerebral Tumor. Cancer Research 40:3163–3166, 1980
Fong KL, Ho DHW, Yap BS, Stewart DJ, Brown NS, Benjamin RS, Freireich EJ, Bodey GP: Clinical pharmacology of IMPY by radio-immunoassay. Cancer Treat Rep 64:1253–1260, 1980
Rosenblum M, Stewart DJ, Yap BS, Leavens M, Benjamin RS, Loo TL: Penetration of Methylglyoxal Bis(guanylhydrazone) into intracerebral tumors in humans. Cancer Research 41:459–462, 1981
Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Research 42:2474–2479, 1982
Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallace S, Chuang V, Calvo III D, Samuels M, Bonura J, Loo TL: Clinical pharmacology of intra-arterial cis-diamminedichloroplatinum (II). Cancer Research 43:917–920, 1983
Savaraj N, Lu K, Feun LG, Leavens ME, Stewart DJ, Burgess MA, Benjamin RS, Loo TL: Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ NSC 182986). J NeuroOncology 1:15–20, 1983
Stewart DJ, Lu K, Benjamin RS, Leavens M, Luna M, Yap HY, Loo TL: Concentrations of vinblastine in human intracerebral tumor and other tissues. J Neuro-Oncology 1:139–144, 1983
Zhengang G, Savaraj N, Feun LG, Lu K, Stewart DJ, Luna M, Benjamin RS, Loo TL: Tumor penetration of AMSA in man. Cancer Investigation 1:475–478, 1983
Stewart DJ, Richard M, Hugenholtz H, Dennery J, Belanger R, Gerin-Lajoie J, Montpetit V, Nundy D, Prior J, Hopkins H: Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors. J Neuro-Oncology 2:133–139, 1984
Stewart DJ, Richard MT, Hugenholtz H, Dennery J, Nundy D, Prior J, Montpetit V, Hopkins HS: Penetration of teniposide (VM-26) into human intracerebral tumors: Preliminary observations on the effect of tumor type, rate of drug infusion and prior treatment with amphotericin-B or oral glycerol. J Neuro-Oncology 2:315–324, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stewart, D.J., Maroun, J.A., Hugenholtz, H. et al. Combined intraommaya methotrexate, cytosine arabinoside, hydrocortisone and thio-TEPA for meningeal involvement by malignancies. J Neuro-Oncol 5, 315–322 (1987). https://doi.org/10.1007/BF00148388
Issue Date:
DOI: https://doi.org/10.1007/BF00148388